"Paliperidone Palmitate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A benzisoxazole derivative and active metabolite of RISPERIDONE that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST and SEROTONIN 5-HT2 RECEPTOR ANTAGONIST. It is an ANTIPSYCHOTIC AGENT used in the treatment of SCHIZOPHRENIA.
| Descriptor ID |
D000068882
|
| MeSH Number(s) |
D03.383.129.385.650 D03.383.742.592
|
| Concept/Terms |
Paliperidone- Paliperidone
- 9-OH-risperidone
- 9 OH risperidone
- 3-(2-(4-(6-fluoro-3-(1,2-benzisoxazolyl))-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one
- 9-Hydroxy-risperidone
- 9 Hydroxy risperidone
- 9-Hydroxyrisperidone
- 9 Hydroxyrisperidone
|
Below are MeSH descriptors whose meaning is more general than "Paliperidone Palmitate".
Below are MeSH descriptors whose meaning is more specific than "Paliperidone Palmitate".
This graph shows the total number of publications written about "Paliperidone Palmitate" by people in this website by year, and whether "Paliperidone Palmitate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Paliperidone Palmitate" by people in Profiles.
-
Adherence, Persistence, Readmissions, and Costs in Medicaid Members with Schizophrenia or Schizoaffective Disorder Initiating Paliperidone Palmitate Versus Switching Oral Antipsychotics: A Real-World Retrospective Investigation. Adv Ther. 2023 Jan; 40(1):349-366.
-
Projecting the Long-Term Economic Impact of Once-Monthly Paliperidone Palmitate Versus Oral Atypical Antipsychotics in Medicaid Patients with Schizophrenia. J Manag Care Spec Pharm. 2020 Feb; 26(2):176-185.
-
Depot antipsychotics: Where do we stand? Ann Clin Psychiatry. 2016 11; 28(4):289-298.